![Sphere that has the top right fourth removed (exposed) Colors from left are orange, dark blue with orange dots, light blue with horizontal lines, then black. Inside the exposure is green and black with boxes.](/sites/default/files/styles/featured_square_large/public/2024-06/slicer.jpg?h=56311bf6&itok=bCZz09pJ)
Filter News
Area of Research
- (-) Biology and Environment (27)
- (-) Isotopes (8)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Clean Energy (64)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (5)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (31)
- Fusion Energy (5)
- Isotope Development and Production (1)
- Materials (78)
- Materials for Computing (7)
- National Security (27)
- Neutron Science (34)
- Nuclear Science and Technology (25)
- Quantum information Science (5)
- Sensors and Controls (1)
- Supercomputing (72)
News Type
News Topics
- (-) Artificial Intelligence (8)
- (-) Biomedical (18)
- (-) Energy Storage (7)
- (-) Machine Learning (7)
- (-) Nuclear Energy (4)
- (-) Physics (2)
- (-) Security (3)
- 3-D Printing/Advanced Manufacturing (9)
- Advanced Reactors (1)
- Big Data (8)
- Bioenergy (35)
- Biology (59)
- Biotechnology (11)
- Buildings (2)
- Chemical Sciences (11)
- Clean Water (8)
- Climate Change (30)
- Composites (4)
- Computer Science (17)
- Coronavirus (12)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (17)
- Environment (70)
- Exascale Computing (4)
- Frontier (3)
- Fusion (1)
- Grid (1)
- High-Performance Computing (17)
- Hydropower (5)
- Isotopes (22)
- Materials (13)
- Materials Science (8)
- Mathematics (3)
- Mercury (6)
- Microscopy (10)
- Molten Salt (1)
- Nanotechnology (7)
- National Security (4)
- Net Zero (2)
- Neutron Science (4)
- Partnerships (5)
- Polymers (2)
- Renewable Energy (1)
- Simulation (13)
- Space Exploration (3)
- Summit (10)
- Sustainable Energy (21)
- Transformational Challenge Reactor (1)
- Transportation (2)
Media Contacts
![Researchers studying secondary metabolites in the fungus Aspergillus flavus, pictured, found unique mixes of metabolites corresponding to genetically distinct populations. The finding suggests local environmental conditions play a key role in secondary metabolite production, influencing the discovery of drugs and other useful compounds. Credit: Tomás Allen Rush/ORNL, U.S. Dept. of Energy.](/sites/default/files/styles/list_page_thumbnail/public/2021-07/DSC0351.jpg?h=b2d9f031&itok=PNgYY5eW)
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Targeted alpha therapy can deliver radiation to specific cells, with minimal effect on surrounding, healthy cells. Credit: Michelle Lehman and Jaimee Janiga/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/gif_high_res.gif?h=ae1281eb&itok=QtNBjm3O)
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
![Verónica Melesse Vergara speaks with third and fourth graders at East Side Intermediate School in Brownsville. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-02/EWeek_vergara_0.jpg?h=c44fcfa1&itok=-FdYpHed)
Twenty-seven ORNL researchers Zoomed into 11 middle schools across Tennessee during the annual Engineers Week in February. East Tennessee schools throughout Oak Ridge and Roane, Sevier, Blount and Loudon counties participated, with three West Tennessee schools joining in.
![Brian Damiano](/sites/default/files/styles/list_page_thumbnail/public/2020-12/2016-P04442.jpg?h=49ab6177&itok=lPIC-H6L)
Brian Damiano, head of the Centrifuge Engineering and Fabrication Section, has been elected fellow of the American Society of Mechanical Engineers.
![Distinguished Inventors](/sites/default/files/styles/list_page_thumbnail/public/2020-12/inventors.jpg?h=4631f1c1&itok=xhAGY0kv)
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
![asset management](/sites/default/files/styles/list_page_thumbnail/public/2023-05/Picture9.png?h=cf4f3851&itok=rVU02eNT)
East Tennessee occupies a special place in nuclear history. In 1943, the world’s first continuously operating reactor began operating on land that would become ORNL.
![coronavirus](/sites/default/files/styles/list_page_thumbnail/public/2020-11/coronavirus_top10%20%28002%29.png?h=997b30da&itok=7I6TjG_l)
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.